Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.

The Journal of Clinical Investigation
Carolyn Waugh KinkadeCory Abate-Shen

Abstract

The AKT/mammalian target of rapamycin (AKT/mTOR) and ERK MAPK signaling pathways have been shown to cooperate in prostate cancer progression and the transition to androgen-independent disease. We have now tested the effects of combinatorial inhibition of these pathways on prostate tumorigenicity by performing preclinical studies using a genetically engineered mouse model of prostate cancer. We report here that combination therapy using rapamycin, an inhibitor of mTOR, and PD0325901, an inhibitor of MAPK kinase 1 (MEK; the kinase directly upstream of ERK), inhibited cell growth in cultured prostate cancer cell lines and tumor growth particularly for androgen-independent prostate tumors in the mouse model. We further showed that such inhibition leads to inhibition of proliferation and upregulated expression of the apoptotic regulator Bcl-2-interacting mediator of cell death (Bim). Furthermore, analyses of human prostate cancer tissue microarrays demonstrated that AKT/mTOR and ERK MAPK signaling pathways are often coordinately deregulated during prostate cancer progression in humans. We therefore propose that combination therapy targeting AKT/mTOR and ERK MAPK signaling pathways may be an effective treatment for patients with adva...Continue Reading

References

Apr 24, 1999·Genes & Development·R Bhatia-GaurM M Shen
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·K PodsypaninaR Parsons
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·M S NeshatC L Sawyers
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Minjung J KimCory Abate-Shen
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward P Gelmann
Mar 22, 2003·Lancet·Angelo M DeMarzoJonathan I Epstein
Oct 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Chang-Hyuk KwonSuzanne J Baker
Dec 12, 2003·Cancer Cell·Charles L Sawyers
Aug 18, 2004·Genes & Development·Nissim Hay, Nahum Sonenberg
Dec 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Hui GaoCory Abate-Shen
Dec 2, 2004·Nature Reviews. Cancer·Judith S Sebolt-Leopold, Roman Herrera
Dec 18, 2004·Clinical Science·Daniel Gioeli
Feb 3, 2005·Proceedings of the National Academy of Sciences of the United States of America·Andrei KuzmichevDanny Reinberg
Feb 3, 2005·World Journal of Urology·Daniel P Petrylak
Jun 7, 2005·Genes & Development·Céline Gélinas, Eileen White
Sep 17, 2005·CA: a Cancer Journal for Clinicians·Kenneth J Pienta, David C Smith
Nov 8, 2005·Nature·David B SolitNeal Rosen
Nov 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard I Scher, Charles L Sawyers
May 3, 2006·The Prostate·Celeste L KremerRaymond B Nagle
May 25, 2006·Annals of Medicine·Michiaki Kohno, Jacques Pouyssegur
Sep 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hui GaoCory Abate-Shen
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cory Abate-Shen
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenneth P Olive, David A Tuveson
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elena I Fomchenko, Eric C Holland
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brett S Carver, Pier P Pandolfi
Aug 30, 2008·The Journal of Clinical Investigation·Arkaitz CarracedoPier Paolo Pandolfi

❮ Previous
Next ❯

Citations

Jun 15, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Miao-Fen ChenChun-Te Wu
Sep 13, 2011·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Christina D BefaniPanagiotis Liakos
Jun 5, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Chun-Te WuMiao-Fen Chen
Mar 20, 2013·Breast Cancer Research and Treatment·Gauri J SabnisAngela Brodie
May 7, 2011·Targeted Oncology·Jennifer S CarewSteffan T Nawrocki
Jun 23, 2009·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Ruifang MiHongbing Zhang
Aug 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Vincent RouetVincent Goffin
Aug 4, 2010·Proceedings of the National Academy of Sciences of the United States of America·Luc FuricNahum Sonenberg
Dec 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Qihui ShiJames R Heath
Aug 7, 2013·Proceedings of the National Academy of Sciences of the United States of America·Alvaro AytesCory Abate-Shen
Mar 18, 2009·The Journal of Biological Chemistry·Megumi Funakoshi-TagoTadashi Kasahara
Mar 6, 2009·Genes & Development·Anna M Puzio-KuterCory Abate-Shen
Sep 17, 2010·Genes & Development·Michael M Shen, Cory Abate-Shen
Mar 4, 2011·Science Translational Medicine·Andrew S GoldsteinOwen N Witte
Sep 13, 2013·Science Translational Medicine·Shazia IrshadCory Abate-Shen
Mar 29, 2012·Advances in Urology·Marco A De Velasco, Hirotsugu Uemura
Mar 19, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jessica K AltmanLeonidas C Platanias
Sep 10, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rong WuKathleen R Cho
Dec 3, 2009·Cancer Prevention Research·Catherine M SeagerCory Abate-Shen
Aug 30, 2008·The Journal of Clinical Investigation·Arkaitz CarracedoPier Paolo Pandolfi
Aug 30, 2008·The Journal of Clinical Investigation·Steven Grant
Dec 8, 2010·The Journal of Clinical Investigation·Chen ZhaoDouglas Vollrath
Oct 4, 2011·The Journal of Clinical Investigation·Helen B PearsonPatrick O Humbert
Jul 23, 2011·Genes & Cancer·Esther Castellano, Julian Downward
Jun 29, 2013·Radiation Oncology·Chun-Te WuChing-Chuan Hsieh
Mar 17, 2012·Disease Models & Mechanisms·Imran AhmadHing Y Leung

❮ Previous
Next ❯

Software Mentioned

SoftMax
CalcuSyn

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.